| Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients A Vijenthira, IY Gong, TA Fox, S Booth, G Cook, B Fattizzo, F Martín-Moro, ... Blood, The Journal of the American Society of Hematology 136 (25), 2881-2892, 2020 | 650 | 2020 |
| COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus L Scarfò, T Chatzikonstantinou, GM Rigolin, G Quaresmini, M Motta, ... Leukemia 34 (9), 2354-2363, 2020 | 281 | 2020 |
| COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ... Leukemia 35 (12), 3444-3454, 2021 | 93 | 2021 |
| Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL A Agathangelidis, A Chatzidimitriou, T Chatzikonstantinou, C Tresoldi, ... Leukemia 36 (8), 1961-1968, 2022 | 55 | 2022 |
| An update in drug-induced thrombotic microangiopathy T Chatzikonstantinou, M Gavriilaki, A Anagnostopoulos, E Gavriilaki Frontiers in Medicine 7, 212, 2020 | 32 | 2020 |
| Endothelial and complement activation as predictors of survival in adult allogeneic hematopoietic cell transplantation E Gavriilaki, I Sakellari, T Chatzikonstantinou, D Mallouri, I Batsis, A Vardi, ... Hemasphere 5 (1), e487, 2021 | 28 | 2021 |
| The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL A Visentin, T Chatzikonstantinou, L Scarfò, A Kapetanakis, ... American journal of hematology 98 (12), 1856-1868, 2023 | 14 | 2023 |
| Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY T Chatzikonstantinou, L Scarfò, G Karakatsoulis, E Minga, D Chamou, ... EClinicalMedicine 65, 2023 | 10 | 2023 |
| Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study S Chatzileontiadou, E Hatjiharissi, M Angelopoulou, JV Asimakopoulos, ... Frontiers in Oncology 13, 1128994, 2023 | 10 | 2023 |
| COVID-19 and chronic lymphocytic leukemia: where we stand now T Chatzikonstantinou, Y Herishanu, E Montserrat, P Ghia, A Cuneo, R Foa, ... The Cancer Journal 27 (4), 328-333, 2021 | 10 | 2021 |
| Challenges and solutions for collecting and analyzing real world data: the Eric CLL database as an illustrative example A Chatzidimitriou, E Minga, T Chatzikonstantinou, C Moreno, ... Hemasphere 4 (5), e425, 2020 | 10 | 2020 |
| Biology and treatment of high-risk CLL: significance of complex karyotype T Chatzikonstantinou, C Demosthenous, P Baliakas Frontiers in Oncology 11, 788761, 2021 | 9 | 2021 |
| Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL D Antic, N Milic, T Chatzikonstantinou, L Scarfò, V Otasevic, N Rajovic, ... Journal of hematology & oncology 15 (1), 116, 2022 | 8 | 2022 |
| Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer E Fountzilas, K Papadopoulou, T Chatzikonstantinou, G Karakatsoulis, ... Cancers 15 (23), 5525, 2023 | 7 | 2023 |
| Real-world data of thrombotic microangiopathy management: the key role of ADAMTS13 activity and complement testing E Gavriilaki, EE Koravou, T Chatziconstantinou, C Kalpadaki, N Printza, ... Thrombosis Update 3, 100043, 2021 | 7 | 2021 |
| Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data E Gavriilaki, E Nikolousis, EE Koravou, S Dimou-Besikli, C Kartsios, ... Frontiers in Medicine 10, 1226114, 2023 | 6 | 2023 |
| Worldwide examination of patients with CLL hospitalized for COVID-19 LE Roeker, L Scarfo, T Chatzikonstantinou, P Abrisqueta, TA Eyre, ... Blood 136, 45-49, 2020 | 6 | 2020 |
| ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—2024 update J Malcikova, S Pavlova, P Baliakas, T Chatzikonstantinou, E Tausch, ... Leukemia, 1-14, 2024 | 5 | 2024 |
| Caplacizumab for acquired thrombotic thrombocytopenic purpura: real-world multicenter data on re-administration and plasma exchange free treatment E Gavriilaki, E Koravou, S Dimou-Mpesikli, E Nikolousis, A Banti, ... Blood 140 (Supplement 1), 8503-8504, 2022 | 5 | 2022 |
| Predictors of transplant-associated thrombotic microangiopathy in patients with overlap or chronic graft-vs-host-disease E Gavriilaki, I Sakellari, T Chatzikonstantinou, Z Bousiou, D Mallouri, ... Transplantation Proceedings 53 (7), 2261-2266, 2021 | 5 | 2021 |
